Close Menu


Some have questioned the paper's claim that it takes "at least 35-40 machine runs with many instruments operating in parallel" and reagent costs of a quarter to a half a million dollars to sequence a human genome on other instruments.

Under the Phenotypic Drug Discovery program, researchers from academia or biotech submit candidate compounds in specific therapeutic areas for Lilly to evaluate and profile. Participating organizations retain full IP rights to the compounds, but Lilly receives first rights to negotiate a broader collaboration or licensing agreement.

Eiger Biopharma licenses Hep C Rx IP from Stanford; TapImmune buys vaccine IP from UBC; Acetylon Pharma closes $7.25M series A to commercialize Dana-Farber, Harvard HDAC inhibitors; EMD Serono and MD Anderson ink clinical trial pact; U of Queensland's IMBcom licenses HGH receptor cell lines to Prolor Biotech

Researchers from Stanford University reported in Nature Biotechnology today that they have sequenced the genome of a Caucasian man using a Helicos Heliscope, a single molecule sequencing platform.

Tony Wyss-Coray and his colleagues used a peptide microarray platform to identify the antibodies, which are found at higher levels in younger people than older ones, suggesting they may protect against Alzheimer's. If the findings pan out, it could provide the basis for a vaccine against the disease.

IP Roundup: Jun 30, 2009


Qiagen, University of Michigan, Enzo Life Sciences, Stanford University, BioMerieux

The agreement comes approximately three months after ABL and Stanford reached their own settlement in the suit, in which ABL accused the university and professor of breaching a patent immunity contract regarding Stanford's HIV Drug Resistance Database.

The former PhD student this week filed an amended complaint claiming his faculty advisor plagiarized his PhD dissertation and lab notebooks to support additional patent applications for a gene-modification technique he helped invent.

The Canary Foundation is providing $15 million to start the early cancer detection research center at Stanford.


ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.